Back to Top Skip to main content

New equipment at Camp Lemonnier improves blood storage

Hospital Corpsmen 2nd Class Andrew Kays (right) and Christi Greenwood (left), deployed with the Expeditionary Medical Facility at Camp Lemonnier, receive training on the Automated Cell Processor 215 while Hospital Corpsman 2nd Class Joshua Paddlety from Naval Hospital Sigonella, Italy, as part of implementation of the Frozen Blood Program here, March 13, 2019. (U.S. Navy photo by Mass Communication Specialist 1st Class Joe Rullo) Navy Hospital Corpsmen 2nd Class Andrew Kays (right) and Christi Greenwood (left), deployed with the Expeditionary Medical Facility at Camp Lemonnier, receive training on the Automated Cell Processor 215 while Navy Hospital Corpsman 2nd Class Joshua Paddlety from Naval Hospital Sigonella, Italy, as part of implementation of the Frozen Blood Program here, March 13, 2019. (U.S. Navy photo by Mass Communication Specialist 1st Class Joe Rullo)

Recommended Content:

Health Readiness | Armed Services Blood Program | Military Hospitals and Clinics

CAMP LEMONNIER, Djibouti — Many people have donated blood at one time or another to support their local community in a time of need. Service members see that same need during a mass casualty situation that may occur in a forward-deployed area.

Getting people to donate is only the first step in keeping a sufficient supply of blood on hand in case of an emergency. Storing donated blood poses its own unique challenges for medical treatment facilities in austere environments. The Expeditionary Medical Facility (EMF) at Camp Lemonnier, Djibouti, is one of those facilities; until now.

EMF received new equipment March 15, 2019 as part of the Frozen Blood Program that will allow for the longer storage of red blood cells, significantly increasing the shelf life of blood on the base.

The new equipment, called Automated Cell Processor 215 (ACP 215), provides a safe way to freeze, thaw and wash red blood cells. Red cells are glycerolized, deglycerolized and washed in a closed disposable system and automatically re-suspended in additive solution to permit extended product storage post washing, according to Haemonetics Inc., the company that manufactures the equipment.

Blood that is collected and currently stored in medical refrigerators at EMF expires three to four weeks after collection. Frozen blood, which is stored at negative 70-degrees Celsius, can be used for up to 10 years.

The Officer in Charge of EMF at Camp Lemonnier, Navy Cmdr. Edward H. Owens, said the technology will significantly enhance EMF's mission capability as the sole U.S. Role-2-Plus medical facility on the African continent.

“I think we all know and appreciate the benefits blood products bring to the overall survival of patients in need,” Owens said. “But we may not fully understand the logistical challenges that exist in shipping liquid blood, as well as the amount of effort that goes into maintaining a Walking Blood Program. Having this technology will lesson those logistical challenges and reduce our required levels of liquid blood.”

As a Role-2-Plus facility, EMF is able to perform routine hematology, chemistry and urinalysis as well as a battery of point-of-care tests for infection and tropical diseases such as Malaria and Dengue fever.

The Walking Blood Program is used military-wide to identify and screen qualified blood donors to provide fresh whole blood for wounded service members.

Navy Hospital Corpsman 2nd Class Christi Greenwood, an EMF lab technician, said the medical facility at Camp Lemonnier receives its frozen blood units from the Armed Services Blood Bank Center, Europe, since locally there isn’t a way to freeze collected units.

“Donated blood is separated into the component red blood cells and plasma,” Greenwood said.” The red blood cells are then mixed with glycerol and frozen prior to shipment.”

The ACP 215 is used to reconstitute the red blood cell. It takes approximately two hours to thaw and process the blood so it is ready for use.

Prior to the equipment arriving, EMF was not able to reconstitute frozen blood; therefore, fresh blood was the only option available.

EMF lab technician Navy Hospital Corpsman 2nd Class Andrew Kays said while the new Frozen Blood Program doesn’t replace the need for chilled blood entirely, it offers the ability to store hundreds of units locally.

“We are able to provide a more reliable blood source for emergencies, drastically reducing the waste of blood products,” said Kays. “We are very excited to help bring this capability to our patients.”

Kays said a Clinical Laboratory Improvement Program (CLIP) certification was performed prior to going live with the new program. This certification is similar to civilian programs that maintain and monitor quality standards for hospitals and independent laboratories.

“Attainment of CLIP certification is a major milestone for EMF as we strive to provide world-class care to Camp Lemonnier and its tenant commands,” Kays said.

Owens said being able to provide the kind of care this new equipment covers will significantly enhance EMF’s mission.

“Having this capability will enable us to partner with Combined Joint Task Force-Horn of Africa Surgeon Cell to support warfighters down range," Owens said.

Camp Lemonnier is an operationally-focused shore installation that enables U.S., allied and partner nation forces to be where and when they are needed to ensure security and stability in Europe, Africa and Southwest Asia.

The mission of Camp Lemonnier is to enable joint warfighters operating forward and to reinforce the relationship between the United States and Djibouti by conducting five key shore missions – air operations, port operations, security, safety and quality of life – and providing core mission enablers such as fuel, water and power for tenant commands, transient U.S. assets and individual service members.

Disclaimer: Re-published content may have been edited for length and clarity.  Read original post.

You also may be interested in...

DHA IPM 19-003: Reserve Health Readiness Program

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (i): • Provides utilization guidance and funding requirements for the RHRP contract to supplement Reserve Component Individual Medical Readiness (IMR) and Deployment Health activities when Service organic health readiness resources are not available to meet mission requirements. • Provides utilization guidance and funding requirements for the RHRP contract for Active Duty enrolled in TRICARE Prime Remote, U.S. Coast Guard (USCG), USCG Reserves, and re-deploying DoD civilians (e.g., U.S. Army Corps of Engineers and U.S. Army Intelligence and Security Command). • Communicate procedure guidance to all DoD organizations utilizing RHRP services. • Will expire effective 12 months from the date of issue and be converted to a DHA-Procedural Instruction.

  • Identification #: 19-003
  • Date: 3/8/2019
  • Type: DHA Interim Procedures Memorandum
  • Topics: Health Readiness

Implementing Congressional Direction for Reform of the Military Health System

Policy

Policy Memorandum, signed by Deputy Secretary of Defense Patrick M. Shanahan, to direct implementation of the Military Health System (MHS) organizational reform required by the National Defense Authorization Act.

DHA IPM 18-008: Use of Medical Q Services (MQS) Contract by Military Treatment Facilities (MTFs)

Policy

This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), based on the authority of References (a) through (d): - Instructs MTFs and servicing contracting offices to use the DHA MQS contracts for the procurement of health care staffing requirements for market segments of physician, nurse, dental, and ancillary contract services in the United States and its Territories. - Is effective immediately; it must be incorporated into a forthcoming change to DHA Procedural Instruction 6025.05 (Reference (g)). This DHA-IPM will expire effective 12 months from the date of issue.

DHA PI 6025.07: Naloxone in the MTFs

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) through (c), and in accordance with the guidance of References (d) through (h), establishes the Defense Health Agency’s (DHA) procedures for prescribing and dispensing naloxone by pharmacists in MTFs to eligible beneficiaries, upon beneficiary request, or when the pharmacist determines the beneficiary meets the established criteria for being at risk for a life-threatening opiate overdose.

DHA PI 6200.05: Force Health Protection Quality Assurance (FHPQA) Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (ab), establishes the procedures for the FHPQA Program as defined in Reference (z). This DHA-PI applies to: a. OSD, the Military Departments (including the United States Coast Guard (USCG) at all times, including when it is a Service in the Department of Homeland Security by agreement with that Department), the Office of the Chairman of the Joint Chiefs of Staff (CJCS) and the Joint Staff, the Combatant Commands, the Office of the Inspector General of the DoD, the Defense Agencies, the DoD Field Activities, and all other organizational entities within the DoD (referred to collectively in this DHA-PI as the “DoD Components”). b. Civilian personnel, as defined in Reference (e), and DoD contractor personnel authorized to accompany the force (CAAF), in accordance with References (j), (m), and (n), respectively.

  • Identification #: DHA PI 6200.05
  • Date: 5/2/2018
  • Type: DHA Procedural Instruction
  • Topics: Health Readiness

DoD Instruction 6200.05: Force Health Protection Quality Assurance (FHPQA) Program

Policy

This issuance establishes policy, assigns responsibilities, and defines requirements for the development and establishment of the FHPQA Program in accordance with the authority in DoD Directive (DoDD) 5124.02, Sections 731 and 738 of Public Law 108-375; Sections 1074f, 1092a, and 1073b of Title 10, United States Code; and DoDDs 6200.04 and 5136.13.

Guidance Regarding Zika Dengue and Chikungunya Viruses

Policy

This guidance contains information about the potential for transfusion-transmitted Zika infection; recommends facilitating donor self-deferral of 28 days after travel to Mexico, the Caribbean, Central America and South America.

DoD Instruction 6490.13: Comprehensive Policy on Traumatic Brain Injury-Related Neurocognitive Assessments by the Military Services

Policy

This instruction establishes policy, assigns responsibilities, and prescribes standard elements, pursuant to section 722 of Public Law 111-383, requiring the implementation of a comprehensive neurocognitive assessment policy in the Military Services.

Embedded Fragment Analyses

Policy

Clarification of the Requirement for Continuation of Semi-Annual Reporting of Results of Embedded Fragment Analyses

Detecting and Reporting DoD Cases of Ebola Virus Disease Infection

Policy

Guidance as of 17 OCT 2014 from the Department of Defese (AFHSC)for Detecting and Reporting DoD Cases of Ebola Virus Disease Infection

Influenza Surveillance Program

Policy

Sentinel Sites for the 2014-2015 Influenza Surveillance Program

Military Health System Prescription Transfer Procedures

Policy

Effective immediately, all Department of Defense (DoD) military treatment facility (MTF) outpatient pharmacies will accept patient requests for prescription transfers from another MTF and from retail pharmacies. When another pharmacy requests prescription transfer information on behalf of a patient, DoD MTF outpatient pharmacies will respond to the inquirer in a timely manner.

Deployment Limiting Mental Disorders and Psychotrophic Medications

Policy

Policy memorandum about Deployment Limiting Mental Disorders and Psychotrophic Medications

DoD Directive 6000.12E: Health Service Support

Policy

This directive designates the Secretary of the Army as the DoD Executive Agent for the Armed Services Blood Program Office (ASBPO) (Reference (h)), who exercises this authority through the Surgeon General of the Army, in accordance with DoDD 5101.1 (Reference (d)).

DoD Instruction 6480.04: Armed Services Blood Program Operational Procedures

Policy

This instruction assign responsibilities, and prescribe procedures to carry out the responsibilities of the Armed Services Blood Program (ASBP) during peacetime, contingency, and wartime operations.

<< < 1 2 3 > >> 
Showing results 1 - 15 Page 1 of 3

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing: Download a PDF Reader or learn more about PDFs.